Menu Search
Equities

N4 Pharma PLC

N4P:LSE

N4 Pharma PLC

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (GBX)0.70
  • Today's Change0.05 / 7.69%
  • Shares traded5.78k
  • 1 Year change-9.68%
  • Beta-1.1412
Data delayed at least 20 minutes, as of Nov 22 2024 16:05 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in GBPView more

In 2023, cash reserves at N4 Pharma PLC fell by 892.42k. Cash Flow from Financing totalled 312.23k or 16,011.79% of revenues. In addition the company used 1.21m for operations while cash from investing totalled 780.00.
Cash flow per share--
Price/Cash flow per share--
Book value per share0.0032
Tangible book value per share0.003
More ▼

Balance sheet in GBPView more

N4 Pharma PLC appears to have little financial risk as the company holds a substantial amount of cash on its books with little or no debt.
Current ratio22.73
Quick ratio--
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.